register

News & Trends - MedTech & Diagnostics

Abbott accelerates test launch to combat the COVID-19 pandemic

Health Industry Hub | March 24, 2020 |

MedTech News: Abbott announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorisation (EUA) for the company’s molecular test for novel coronavirus (COVID-19).

Abbott’s Asia Pacific office told Health Industry Hub “We are ramping up our manufacturing capacity. We will communicate country-specific plans as they are determined.”

Abbott is immediately shipping 150,000 Abbott RealTime SARS-CoV-2 EUA tests to customers in the U.S. The tests are used on the company’s m2000™ RealTime System.

“A global challenge like coronavirus requires the commitment and cooperation of everyone who has the ability to help address it,” said Miles D. White, chairman and chief executive officer, Abbott. “I’m proud of the Abbott team and what they’ve accomplished in such a short period of time, and I want to thank the Administration and the FDA for their partnership in making this happen.”

Customer engagement during COVID-19. Health Industry Hub combines expertise in delivering digital health content and measuring engagement with 20+ years industry experience. Created by industry for industry.

The m2000 Molecular Platform has the ability to run high volumes of up to 470 tests in 24 hours, helping to meet the increasing demand for testing. Many of these instruments are used in university and community hospitals where patients come for care, resulting in testing that happens closer to the patient rather than sending it to an offsite lab.

Abbott will continue ramping up production to the highest levels possible, with the goal of providing up to 1 million tests per week. Abbott is manufacturing these tests in the U.S.


News & Trends - Pharmaceuticals

Sanofi's departing Country Lead leaves three-decade legacy of strategic, compassionate leadership

Sanofi’s departing Country Lead leaves three-decade legacy of strategic, compassionate leadership

Health Industry Hub | April 17, 2024 |

Pharma News: In a significant development for Sanofi’s local operations, Karen Hood, a seasoned leader with 28 years of invaluable […]

More


Human Resources

AbbVie appoints new HR Director with diverse expertise across healthcare

AbbVie appoints new HR Director with diverse expertise across healthcare

Health Industry Hub | April 17, 2024 |

AbbVie has appointed a new Human Resources Director for Australia and New Zealand. Ally Jonas assumed the role earlier this […]

More


Digital & Innovation

Department of Health hits milestone in digital transformation

Department of Health hits milestone in digital transformation

Health Industry Hub | April 17, 2024 |

Digital & Innovation: The Department of Health and Aged Care has reached the midpoint of its digital transformation journey. While […]

More


News & Trends - Pharmaceuticals

Paradigm-changing outcomes for patients with acute myeloid leukaemia

Paradigm-changing outcomes for patients with acute myeloid leukaemia

Health Industry Hub | April 17, 2024 |

Pharma News: Australian researchers have found a new combination treatment to treat a form of leukaemia that prolongs remission. A […]

More


This content is copyright protected. Please subscribe to gain access.